Rishi Jayant Khusial
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rishi Jayant Khusial has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Jacob K. Sont
Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, the Netherlands
6 shared publications - Persijn J. Honkoop
South Link Health Inc, Dundedin, New Zealand
4 shared publications Jacob K. Sont
Department of Biomedical Data Sciences, section Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands
3 shared publicationsJiska B. Snoeck-Stroband
Department of Biomedical Data Sciences, section Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands
3 shared publications- Lucia Rijssenbeek-Nouwens
Dutch Asthma Centre Davos Davos Switzerland
3 shared publications Persijn Honkoop
3 shared publications
Latest Publications
- Open Access
- 11 December 2024
- Published by JMIR Publications Inc. in JMIR Cardio
- Vol. 8, e56848
The Effect of Inhaled Beta-2 Agonists on Heart Rate in Patients With Asthma: Sensor-Based Observational Study
Background: Beta-2 agonists play an important role in the management of asthma. Inhaled long-acting beta-2 agonists (LABAs) and short-acting beta-2 agonists (SABAs) cause bronchodilation by stimulating adrenoceptors. These receptors are also present in cardiac cells and, as a side effect, could also be stimulated by inhaled beta-2 agonists. Objective: This study aims to assess the effect of beta-2 agonists on heart rate (HR). Methods: The data were retrieved from an observational study, the myAirCoach Quantification Campaign. Beta-2 agonist use was registered by self-reported monthly questionnaires and by smart inhalers. HR was monitored continuously with the Fitbit Charge HR tracker (Fitbit Inc). Patients (aged 18 years and older) were recruited if they had uncontrolled asthma and used inhalation medication. Our primary outcome was the difference in HR between LABA and non-LABA users. Secondary outcomes were the difference in HR on days SABAs were used compared to days SABAs were not used and an assessment of the timing of inhaler use during the day. Results: Patients using LABA did not have a clinically relevant higher HR (average 0.8 beats per minute difference) during the day. Around the moment of SABA inhalation itself, the HR does increase steeply, and it takes 138 minutes before it returns to the normal range. Conclusions: This study indicates that LABAs do not have a clinically relevant effect on HR. SABAs are instead associated with a short-term HR increase. Trial Registration: ClinicalTrials.gov NCT02774772; https://clinicaltrials.gov/study/NCT02774772
- 11 December 2024
- Published by JMIR Publications Inc. in JMIR Cardio
- Vol. 8, e56848
Open AccessThe Effect of Inhaled Beta-2 Agonists on Heart Rate in Patients With Asthma: Sensor-Based Observational Study
Background: Beta-2 agonists play an important role in the management of asthma. Inhaled long-acting beta-2 agonists (LABAs) and short-acting beta-2 agonists (SABAs) cause bronchodilation by stimulating adrenoceptors. These receptors are also present in cardiac cells and, as a side effect, could also be stimulated by inhaled beta-2 agonists. Objective: This study aims to assess the effect of beta-2 agonists on heart rate (HR). Methods: The data were retrieved from an observational study, the myAirCoach Quantification Campaign. Beta-2 agonist use was registered by self-reported monthly questionnaires and by smart inhalers. HR was monitored continuously with the Fitbit Charge HR tracker (Fitbit Inc). Patients (aged 18 years and older) were recruited if they had uncontrolled asthma and used inhalation medication. Our primary outcome was the difference in HR between LABA and non-LABA users. Secondary outcomes were the difference in HR on days SABAs were used compared to days SABAs were not used and an assessment of the timing of inhaler use during the day. Results: Patients using LABA did not have a clinically relevant higher HR (average 0.8 beats per minute difference) during the day. Around the moment of SABA inhalation itself, the HR does increase steeply, and it takes 138 minutes before it returns to the normal range. Conclusions: This study indicates that LABAs do not have a clinically relevant effect on HR. SABAs are instead associated with a short-term HR increase. Trial Registration: ClinicalTrials.gov NCT02774772; https://clinicaltrials.gov/study/NCT02774772
- Open Access
- 28 January 2024
- Published by JMIR Publications Inc. in JMIR Preprints
The Effect of Inhaled Beta-2 Agonists on Heart Rate in Patients With Asthma: Sensor-Based Observational Study (Preprint)
BACKGROUND Beta-2 agonists play an important role in the management of asthma. Inhaled long-acting beta-2 agonists (LABAs) and short-acting beta-2 agonists (SABAs) cause bronchodilation by stimulating adrenoceptors. These receptors are also present in cardiac cells and, as a side effect, could also be stimulated by inhaled beta-2 agonists. OBJECTIVE This study aims to assess the effect of beta-2 agonists on heart rate (HR). METHODS The data were retrieved from an observational study, the myAirCoach Quantification Campaign. Beta-2 agonist use was registered by self-reported monthly questionnaires and by smart inhalers. HR was monitored continuously with the Fitbit Charge HR tracker (Fitbit Inc). Patients (aged 18 years and older) were recruited if they had uncontrolled asthma and used inhalation medication. Our primary outcome was the difference in HR between LABA and non-LABA users. Secondary outcomes were the difference in HR on days SABAs were used compared to days SABAs were not used and an assessment of the timing of inhaler use during the day. RESULTS Patients using LABA did not have a clinically relevant higher HR (average 0.8 beats per minute difference) during the day. Around the moment of SABA inhalation itself, the HR does increase steeply, and it takes 138 minutes before it returns to the normal range. CONCLUSIONS This study indicates that LABAs do not have a clinically relevant effect on HR. SABAs are instead associated with a short-term HR increase. CLINICALTRIAL ClinicalTrials.gov NCT02774772; https://clinicaltrials.gov/study/NCT02774772
- 28 January 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe Effect of Inhaled Beta-2 Agonists on Heart Rate in Patients With Asthma: Sensor-Based Observational Study (Preprint)
BACKGROUND Beta-2 agonists play an important role in the management of asthma. Inhaled long-acting beta-2 agonists (LABAs) and short-acting beta-2 agonists (SABAs) cause bronchodilation by stimulating adrenoceptors. These receptors are also present in cardiac cells and, as a side effect, could also be stimulated by inhaled beta-2 agonists. OBJECTIVE This study aims to assess the effect of beta-2 agonists on heart rate (HR). METHODS The data were retrieved from an observational study, the myAirCoach Quantification Campaign. Beta-2 agonist use was registered by self-reported monthly questionnaires and by smart inhalers. HR was monitored continuously with the Fitbit Charge HR tracker (Fitbit Inc). Patients (aged 18 years and older) were recruited if they had uncontrolled asthma and used inhalation medication. Our primary outcome was the difference in HR between LABA and non-LABA users. Secondary outcomes were the difference in HR on days SABAs were used compared to days SABAs were not used and an assessment of the timing of inhaler use during the day. RESULTS Patients using LABA did not have a clinically relevant higher HR (average 0.8 beats per minute difference) during the day. Around the moment of SABA inhalation itself, the HR does increase steeply, and it takes 138 minutes before it returns to the normal range. CONCLUSIONS This study indicates that LABAs do not have a clinically relevant effect on HR. SABAs are instead associated with a short-term HR increase. CLINICALTRIAL ClinicalTrials.gov NCT02774772; https://clinicaltrials.gov/study/NCT02774772
- Open Access
- 22 November 2022
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 6 (11) , e26925
Patients’ and Health Care Providers’ Perceptions on mHealth Use After High-Altitude Climate Therapy for Severe Asthma: Mixed Methods Study
Background: Asthma is a common chronic disease with various clinical presentations. Although most patients are able to reach good asthma control, some patients are not able to reach sufficient asthma control following the regular treatment guidelines and could be referred to high-altitude climate therapy (HACT). HACT includes environmental trigger avoidance in the alpine climate with multidisciplinary clinical treatment. Patients with severe and difficult-to-control asthma, who are unable to reach asthma control at sea level, can follow a 12-week lung rehabilitation program at 1600 m above sea level. Mobile health (mHealth) tools can be used to enhance self-management in these patients when they return home. For an mHealth system to be effective, it must meet the expectations of the end users. Objective: In this Davos@home study, we explored the attitudes toward mHealth aimed at supporting the self-management of patients with severe, difficult-to-control asthma who underwent HACT and asthma health care providers. Methods: In the first stage, interviews with referrers to HACT and focus groups with patients with asthma who participated in or completed HACT were conducted. The data were then analyzed thematically. On the basis of these results, a questionnaire was developed. In the second stage of the study, this questionnaire, combined with the Asthma Control Questionnaire and the Individual Innovativeness Questionnaire, was provided to patients who completed HACT. Results: In total, 11 interviews and 3 focus groups (n=18, age 47.6, SD 12.1 years, Asthma Control Questionnaire score 2.6, SD 1.0) were conducted. A total of 3 themes were identified: potential goals, useful measurements, and perceived barriers and facilitators. The questionnaire developed in stage 2 included items based on these results. The most agreed-upon goal among the 52 patients who completed the questionnaire was to increase their asthma control (45/52, 86% of the patients). Conclusions: Different patients reported that they would benefit the most from different functionalities. Therefore, it is important to tailor functionalities to individual (treatment) goals. When developing an mHealth intervention, it is important to allow personalization to avoid overwhelming the users.
- 22 November 2022
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 6 (11) , e26925
Open AccessPatients’ and Health Care Providers’ Perceptions on mHealth Use After High-Altitude Climate Therapy for Severe Asthma: Mixed Methods Study
Background: Asthma is a common chronic disease with various clinical presentations. Although most patients are able to reach good asthma control, some patients are not able to reach sufficient asthma control following the regular treatment guidelines and could be referred to high-altitude climate therapy (HACT). HACT includes environmental trigger avoidance in the alpine climate with multidisciplinary clinical treatment. Patients with severe and difficult-to-control asthma, who are unable to reach asthma control at sea level, can follow a 12-week lung rehabilitation program at 1600 m above sea level. Mobile health (mHealth) tools can be used to enhance self-management in these patients when they return home. For an mHealth system to be effective, it must meet the expectations of the end users. Objective: In this Davos@home study, we explored the attitudes toward mHealth aimed at supporting the self-management of patients with severe, difficult-to-control asthma who underwent HACT and asthma health care providers. Methods: In the first stage, interviews with referrers to HACT and focus groups with patients with asthma who participated in or completed HACT were conducted. The data were then analyzed thematically. On the basis of these results, a questionnaire was developed. In the second stage of the study, this questionnaire, combined with the Asthma Control Questionnaire and the Individual Innovativeness Questionnaire, was provided to patients who completed HACT. Results: In total, 11 interviews and 3 focus groups (n=18, age 47.6, SD 12.1 years, Asthma Control Questionnaire score 2.6, SD 1.0) were conducted. A total of 3 themes were identified: potential goals, useful measurements, and perceived barriers and facilitators. The questionnaire developed in stage 2 included items based on these results. The most agreed-upon goal among the 52 patients who completed the questionnaire was to increase their asthma control (45/52, 86% of the patients). Conclusions: Different patients reported that they would benefit the most from different functionalities. Therefore, it is important to tailor functionalities to individual (treatment) goals. When developing an mHealth intervention, it is important to allow personalization to avoid overwhelming the users.
- Open Access
- 10 January 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Davos@home: patient and health care providers’ perceptions on mHealth use after high altitude climate therapy in severe asthma, a mixed methods study. (Preprint)
BACKGROUND High Altitude Climate Therapy (HACT) includes environmental trigger avoidance in the alpine climate with multidisciplinary clinical treatment. Patients with severe and/or difficult-to-control asthma, who are unable to reach asthma control at sea-level, can follow a 12-week lung rehabilitation program at 1600 meters above sea level. Mobile health (mHealth) tools can be used to enhance self-management in these patients when they return home. In order for an mHealth application to be effective, it needs to meet the expectations of the end-users. OBJECTIVE In this Davos@home study we explored the attitudes towards mHealth of severe difficult-to-control asthma patients who underwent HACT and asthma healthcare providers (HCP). METHODS Interviews with referrers to HACT, and focus groups with asthma patients who participated in or finished HACT were conducted. Data were analysed thematically. Based on these results a questionnaire was developed. In the second stage of the study this questionnaire, combined with the Asthma Control Questionnaire and the Individual Innovativeness Questionnaire, was distributed to patients who finished HACT. RESULTS In total 11 interviews and 3 focus groups (n=18, age 47.6, ACQ 2.6) were conducted. Three themes were identified: potential goals, useful measurements, and perceived barriers and facilitators. The questionnaire included items based on the these results. The most agreed upon goal among the 64 patients who filled out the questionnaire was increasing their asthma control (84% of the patients). CONCLUSIONS Different patients reported they would benefit the most from different measures. Therefore it is important to take individual (treatment) goals into consideration. When developing a mHealth intervention it is important to have personalisation options available in order to ensure not to overwhelm the users. CLINICALTRIAL The study was approved by the Medical Ethics Committee of Leiden University Medical Center P19.039).
- 10 January 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDavos@home: patient and health care providers’ perceptions on mHealth use after high altitude climate therapy in severe asthma, a mixed methods study. (Preprint)
BACKGROUND High Altitude Climate Therapy (HACT) includes environmental trigger avoidance in the alpine climate with multidisciplinary clinical treatment. Patients with severe and/or difficult-to-control asthma, who are unable to reach asthma control at sea-level, can follow a 12-week lung rehabilitation program at 1600 meters above sea level. Mobile health (mHealth) tools can be used to enhance self-management in these patients when they return home. In order for an mHealth application to be effective, it needs to meet the expectations of the end-users. OBJECTIVE In this Davos@home study we explored the attitudes towards mHealth of severe difficult-to-control asthma patients who underwent HACT and asthma healthcare providers (HCP). METHODS Interviews with referrers to HACT, and focus groups with asthma patients who participated in or finished HACT were conducted. Data were analysed thematically. Based on these results a questionnaire was developed. In the second stage of the study this questionnaire, combined with the Asthma Control Questionnaire and the Individual Innovativeness Questionnaire, was distributed to patients who finished HACT. RESULTS In total 11 interviews and 3 focus groups (n=18, age 47.6, ACQ 2.6) were conducted. Three themes were identified: potential goals, useful measurements, and perceived barriers and facilitators. The questionnaire included items based on the these results. The most agreed upon goal among the 64 patients who filled out the questionnaire was increasing their asthma control (84% of the patients). CONCLUSIONS Different patients reported they would benefit the most from different measures. Therefore it is important to take individual (treatment) goals into consideration. When developing a mHealth intervention it is important to have personalisation options available in order to ensure not to overwhelm the users. CLINICALTRIAL The study was approved by the Medical Ethics Committee of Leiden University Medical Center P19.039).
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Davos@home: patient and health care providers’ perceptions on mHealth after high altitude climate treatment
Introduction: High Altitude Climate Therapy (HACT) combines trigger avoidance with clinical rehabilitation. Patients with severe asthma, who are unable to reach asthma control, follow a 12-week program at 1600 meters above sea level. Mobile health (mHealth) tools can be used to support self-management when patients return home. In order for an mHealth application to be effective, it needs to meet expectations of end-users. Aim: To explore attitudes towards mHealth of severe, difficult-to-control asthma patients who underwent HACT and asthma healthcare providers (HCP). Method: Interviews with referrers to HACT, and focus groups with asthma patients who underwent or finished HACT were conducted. Transcripts underwent thematic analysis. Based on the results a questionnaire was developed. In the second stage of the study this questionnaire, combined with the Individual Innovativeness questionnaire, was distributed to patients who finished HACT. Results: In total 11 interviews and 3 focus groups (n=18, age 47.6, ACQ 2.59) were conducted. Three themes were created: potential goals, useful measurements and perceived barriers and facilitators. Numerous different goals and functions were named. The questionnaire (n=34) included questions based on the these results. Availability of environmental data (91%) and measuring steps (87%) were the functions with the most support. Conclusion: Different patients reported they would benefit the most from different measures. Therefore it is important to take individual (treatment) goals into consideration and to have personalisation options available in order to ensure not to overwhelm the users.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Davos@home: patient and health care providers’ perceptions on mHealth after high altitude climate treatment
Introduction: High Altitude Climate Therapy (HACT) combines trigger avoidance with clinical rehabilitation. Patients with severe asthma, who are unable to reach asthma control, follow a 12-week program at 1600 meters above sea level. Mobile health (mHealth) tools can be used to support self-management when patients return home. In order for an mHealth application to be effective, it needs to meet expectations of end-users. Aim: To explore attitudes towards mHealth of severe, difficult-to-control asthma patients who underwent HACT and asthma healthcare providers (HCP). Method: Interviews with referrers to HACT, and focus groups with asthma patients who underwent or finished HACT were conducted. Transcripts underwent thematic analysis. Based on the results a questionnaire was developed. In the second stage of the study this questionnaire, combined with the Individual Innovativeness questionnaire, was distributed to patients who finished HACT. Results: In total 11 interviews and 3 focus groups (n=18, age 47.6, ACQ 2.59) were conducted. Three themes were created: potential goals, useful measurements and perceived barriers and facilitators. Numerous different goals and functions were named. The questionnaire (n=34) included questions based on the these results. Availability of environmental data (91%) and measuring steps (87%) were the functions with the most support. Conclusion: Different patients reported they would benefit the most from different measures. Therefore it is important to take individual (treatment) goals into consideration and to have personalisation options available in order to ensure not to overwhelm the users.
- Open Access
- 22 July 2020
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 22 (7) , e13145
Internet-Based Self-Management Support After High-Altitude Climate Treatment for Severe Asthma: Randomized Controlled Trial
Background: In patients with severe asthma, high-altitude climate treatment has been shown to improve asthma control. However, asthma symptoms and limitations may increase after finishing inpatient rehabilitation programs and returning to sea level. Objective: We assessed the effectiveness of a patient-tailored, internet-based, self-management strategy in addition to usual care after finishing high-altitude climate treatment. Methods: We performed a randomized controlled trial with a 1-year follow-up in patients from a high-altitude asthma center in Davos, Switzerland. At the end of a 12-week multidisciplinary rehabilitation program, 62 adults with asthma were randomized to receive either internet-based self-management support in addition to usual care (n=33) or usual care only after discharge (n=29). The endpoints were changes in asthma-related quality of life according to the Asthma Quality of Life Questionnaire (AQLQ) (a higher score is better) and asthma control according to the Asthma Control Questionnaire (ACQ) (a lower score is better), with a minimally important difference of 0.5 points for both. Results: Asthma-related quality of life and asthma control declined over time in the usual care strategy group, whereas there was a slower decline in the internet-based strategy group. For both endpoints, mixed-model analysis showed a significant positive effect in favor of internet-based self-management during follow-up (mean AQLQ score difference 0.39, 95% CI 0.092-0.69; P=.01 and ACQ score difference −0.50, 95% CI −0.86 to −0.15; P=.006), which was prominent among patients with uncontrolled asthma at discharge (AQLQ score difference 0.59, 95% CI 0.19-0.99; P=.003 and ACQ score difference −0.73, 95% CI −1.18 to −0.28; P=.002). Conclusions: Internet-based self-management support was associated with a smaller decline in quality of life and asthma control as compared with usual care, especially in patients with lower asthma control, after completion of high-altitude climate treatment. Internet-based self-management support in adults with severe asthma seems feasible and effective to maintain quality of life and asthma control. Trial Registration: The trial is registered in the Netherlands Trial Register (NTR1995).
- 22 July 2020
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 22 (7) , e13145
Open AccessInternet-Based Self-Management Support After High-Altitude Climate Treatment for Severe Asthma: Randomized Controlled Trial
Background: In patients with severe asthma, high-altitude climate treatment has been shown to improve asthma control. However, asthma symptoms and limitations may increase after finishing inpatient rehabilitation programs and returning to sea level. Objective: We assessed the effectiveness of a patient-tailored, internet-based, self-management strategy in addition to usual care after finishing high-altitude climate treatment. Methods: We performed a randomized controlled trial with a 1-year follow-up in patients from a high-altitude asthma center in Davos, Switzerland. At the end of a 12-week multidisciplinary rehabilitation program, 62 adults with asthma were randomized to receive either internet-based self-management support in addition to usual care (n=33) or usual care only after discharge (n=29). The endpoints were changes in asthma-related quality of life according to the Asthma Quality of Life Questionnaire (AQLQ) (a higher score is better) and asthma control according to the Asthma Control Questionnaire (ACQ) (a lower score is better), with a minimally important difference of 0.5 points for both. Results: Asthma-related quality of life and asthma control declined over time in the usual care strategy group, whereas there was a slower decline in the internet-based strategy group. For both endpoints, mixed-model analysis showed a significant positive effect in favor of internet-based self-management during follow-up (mean AQLQ score difference 0.39, 95% CI 0.092-0.69; P=.01 and ACQ score difference −0.50, 95% CI −0.86 to −0.15; P=.006), which was prominent among patients with uncontrolled asthma at discharge (AQLQ score difference 0.59, 95% CI 0.19-0.99; P=.003 and ACQ score difference −0.73, 95% CI −1.18 to −0.28; P=.002). Conclusions: Internet-based self-management support was associated with a smaller decline in quality of life and asthma control as compared with usual care, especially in patients with lower asthma control, after completion of high-altitude climate treatment. Internet-based self-management support in adults with severe asthma seems feasible and effective to maintain quality of life and asthma control. Trial Registration: The trial is registered in the Netherlands Trial Register (NTR1995).
- Open Access
- 1 June 2020
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 8 (6) , 1972-1979.e8
Effectiveness of myAirCoach: A mHealth Self-Management System in Asthma
- 1 June 2020
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 8 (6) , 1972-1979.e8
Open AccessEffectiveness of myAirCoach: A mHealth Self-Management System in Asthma
- Open Access
- 27 January 2020
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 6 (1)
Validation of online Asthma Control Questionnaire and Asthma Quality of Life Questionnaire
Objective: Several newly developed eHealth applications use online questionnaires to monitor asthma control. The Asthma Control Questionnaire (ACQ) and Asthma Quality of Life Questionnaire (AQLQ) are two such commonly used questionnaires. These questionnaires are validated for use on paper. This study aims to validate them by assessing the agreement between online and paper versions of the ACQ and AQLQ.Methods: Patients (aged 18 years and older) from the Self-Management in Asthma Supported by Hospitals, ICT, Nurses and General Practitioners (SMASHING)-trial and Davos@home study were included in this study. Patients completed both the paper and online Dutch versions of the ACQ and AQLQ in a random order within a 2-week interval. Agreement between the different versions was assessed with paired t-tests, intraclass correlation coefficients and Bland–Altman plots.Results: In total 44 patients were eligible for analysis. The mean difference between the paper and online versions of the ACQ was 0.04 (p=0.40) and for the AQLQ it was 0.08 (p=0.06). The intraclass correlation coefficient scores were 0.94 for the ACQ and 0.95 for the AQLQ.Conclusion: The online versions of the ACQ and AQLQ show high levels of agreement with the paper versions and can therefore be safely used in eHealth applications to respectively monitor asthma control and quality of life.
- 27 January 2020
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 6 (1)
Open AccessValidation of online Asthma Control Questionnaire and Asthma Quality of Life Questionnaire
Objective: Several newly developed eHealth applications use online questionnaires to monitor asthma control. The Asthma Control Questionnaire (ACQ) and Asthma Quality of Life Questionnaire (AQLQ) are two such commonly used questionnaires. These questionnaires are validated for use on paper. This study aims to validate them by assessing the agreement between online and paper versions of the ACQ and AQLQ.Methods: Patients (aged 18 years and older) from the Self-Management in Asthma Supported by Hospitals, ICT, Nurses and General Practitioners (SMASHING)-trial and Davos@home study were included in this study. Patients completed both the paper and online Dutch versions of the ACQ and AQLQ in a random order within a 2-week interval. Agreement between the different versions was assessed with paired t-tests, intraclass correlation coefficients and Bland–Altman plots.Results: In total 44 patients were eligible for analysis. The mean difference between the paper and online versions of the ACQ was 0.04 (p=0.40) and for the AQLQ it was 0.08 (p=0.06). The intraclass correlation coefficient scores were 0.94 for the ACQ and 0.95 for the AQLQ.Conclusion: The online versions of the ACQ and AQLQ show high levels of agreement with the paper versions and can therefore be safely used in eHealth applications to respectively monitor asthma control and quality of life.
- 28 September 2019
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 54 (suppl 63) , PA745
myAirCoach: mHealth assisted self-management in patients with uncontrolled asthma, a randomized control trial
Background: Mobile health (mHealth) could play an important role in assisting patients self-managing their asthma. Therefore we developed the myAirCoach mHealth system to aid self-management. We aimed to assess the effect of the myAirCoach system in addition to usual care on asthma control. Methods: In a randomized controlled trial in the Netherlands we included 30 patients with uncontrolled asthma using a staggered enrolment with 3-7 months follow-up. Patients received either ‘usual care’ or ‘usual care + self-management support via ‘myAirCoach’’. In addition, we performed a 3-month before-after study in 12 patients in the UK. Asthma control was measured with the Asthma Control Questionnaire (ACQ), with a minimal important difference (MID) of 0.5. Secondary outcomes were exacerbation rate and quality of life, measured by the mini Asthma Quality of Life Questionnaire (mAQLQ) with a MID of 0.5. The myAirCoach system consisted of an app, myAirCoach inhaler add-on, indoor air-quality monitor, physical activity tracker, home spirometer and FeNO device. Results: Asthma control improved in the Dutch intervention group compared to controls (ACQ-difference 0.70, p=0.006). A total of 4 severe exacerbations occurred in the intervention group compared to 12 in the control group (hazard ratio 0.22, 95%CI 0.07-0.71, p=0.011). Also quality of life improved significantly (mAQLQ difference 0.53, p= 0.04). In the UK patients, asthma control improved by 0.86 compared to baseline (p=0.007) and quality of life was 0.16 higher (p=0.64). Conclusion: The myAirCoach mHealth self-management system provides an improvement in asthma control and quality of life and a reduction in asthma exacerbation.
- 28 September 2019
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 54 (suppl 63) , PA745
myAirCoach: mHealth assisted self-management in patients with uncontrolled asthma, a randomized control trial
Background: Mobile health (mHealth) could play an important role in assisting patients self-managing their asthma. Therefore we developed the myAirCoach mHealth system to aid self-management. We aimed to assess the effect of the myAirCoach system in addition to usual care on asthma control. Methods: In a randomized controlled trial in the Netherlands we included 30 patients with uncontrolled asthma using a staggered enrolment with 3-7 months follow-up. Patients received either ‘usual care’ or ‘usual care + self-management support via ‘myAirCoach’’. In addition, we performed a 3-month before-after study in 12 patients in the UK. Asthma control was measured with the Asthma Control Questionnaire (ACQ), with a minimal important difference (MID) of 0.5. Secondary outcomes were exacerbation rate and quality of life, measured by the mini Asthma Quality of Life Questionnaire (mAQLQ) with a MID of 0.5. The myAirCoach system consisted of an app, myAirCoach inhaler add-on, indoor air-quality monitor, physical activity tracker, home spirometer and FeNO device. Results: Asthma control improved in the Dutch intervention group compared to controls (ACQ-difference 0.70, p=0.006). A total of 4 severe exacerbations occurred in the intervention group compared to 12 in the control group (hazard ratio 0.22, 95%CI 0.07-0.71, p=0.011). Also quality of life improved significantly (mAQLQ difference 0.53, p= 0.04). In the UK patients, asthma control improved by 0.86 compared to baseline (p=0.007) and quality of life was 0.16 higher (p=0.64). Conclusion: The myAirCoach mHealth self-management system provides an improvement in asthma control and quality of life and a reduction in asthma exacerbation.
- Open Access
- 21 May 2019
- Published by JMIR Publications Inc. in JMIR Preprints
Internet-Based Self-Management Support After High-Altitude Climate Treatment for Severe Asthma: Randomized Controlled Trial (Preprint)
BACKGROUND In patients with severe asthma, high-altitude climate treatment has been shown to improve asthma control. However, asthma symptoms and limitations may increase after finishing inpatient rehabilitation programs and returning to sea level. OBJECTIVE We assessed the effectiveness of a patient-tailored, internet-based, self-management strategy in addition to usual care after finishing high-altitude climate treatment. METHODS We performed a randomized controlled trial with a 1-year follow-up in patients from a high-altitude asthma center in Davos, Switzerland. At the end of a 12-week multidisciplinary rehabilitation program, 62 adults with asthma were randomized to receive either internet-based self-management support in addition to usual care (n=33) or usual care only after discharge (n=29). The endpoints were changes in asthma-related quality of life according to the Asthma Quality of Life Questionnaire (AQLQ) (a higher score is better) and asthma control according to the Asthma Control Questionnaire (ACQ) (a lower score is better), with a minimally important difference of 0.5 points for both. RESULTS Asthma-related quality of life and asthma control declined over time in the usual care strategy group, whereas there was a slower decline in the internet-based strategy group. For both endpoints, mixed-model analysis showed a significant positive effect in favor of internet-based self-management during follow-up (mean AQLQ score difference 0.39, 95% CI 0.092-0.69; P=.01 and ACQ score difference −0.50, 95% CI −0.86 to −0.15; P=.006), which was prominent among patients with uncontrolled asthma at discharge (AQLQ score difference 0.59, 95% CI 0.19-0.99; P=.003 and ACQ score difference −0.73, 95% CI −1.18 to −0.28; P=.002). CONCLUSIONS Internet-based self-management support was associated with a smaller decline in quality of life and asthma control as compared with usual care, especially in patients with lower asthma control, after completion of high-altitude climate treatment. Internet-based self-management support in adults with severe asthma seems feasible and effective to maintain quality of life and asthma control. CLINICALTRIAL The trial is registered in the Netherlands Trial Register (NTR1995).
- 21 May 2019
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessInternet-Based Self-Management Support After High-Altitude Climate Treatment for Severe Asthma: Randomized Controlled Trial (Preprint)
BACKGROUND In patients with severe asthma, high-altitude climate treatment has been shown to improve asthma control. However, asthma symptoms and limitations may increase after finishing inpatient rehabilitation programs and returning to sea level. OBJECTIVE We assessed the effectiveness of a patient-tailored, internet-based, self-management strategy in addition to usual care after finishing high-altitude climate treatment. METHODS We performed a randomized controlled trial with a 1-year follow-up in patients from a high-altitude asthma center in Davos, Switzerland. At the end of a 12-week multidisciplinary rehabilitation program, 62 adults with asthma were randomized to receive either internet-based self-management support in addition to usual care (n=33) or usual care only after discharge (n=29). The endpoints were changes in asthma-related quality of life according to the Asthma Quality of Life Questionnaire (AQLQ) (a higher score is better) and asthma control according to the Asthma Control Questionnaire (ACQ) (a lower score is better), with a minimally important difference of 0.5 points for both. RESULTS Asthma-related quality of life and asthma control declined over time in the usual care strategy group, whereas there was a slower decline in the internet-based strategy group. For both endpoints, mixed-model analysis showed a significant positive effect in favor of internet-based self-management during follow-up (mean AQLQ score difference 0.39, 95% CI 0.092-0.69; P=.01 and ACQ score difference −0.50, 95% CI −0.86 to −0.15; P=.006), which was prominent among patients with uncontrolled asthma at discharge (AQLQ score difference 0.59, 95% CI 0.19-0.99; P=.003 and ACQ score difference −0.73, 95% CI −1.18 to −0.28; P=.002). CONCLUSIONS Internet-based self-management support was associated with a smaller decline in quality of life and asthma control as compared with usual care, especially in patients with lower asthma control, after completion of high-altitude climate treatment. Internet-based self-management support in adults with severe asthma seems feasible and effective to maintain quality of life and asthma control. CLINICALTRIAL The trial is registered in the Netherlands Trial Register (NTR1995).